Literature DB >> 14751749

Calcium sulphate-based cements containing cephalexin.

J C Doadrio1, D Arcos, M V Cabañas, M Vallet-Regí.   

Abstract

Cephalexin containing gypsum and apatite/gypsum cements have been synthesised. The presence of cephalexin into the cements does not alter neither the physico-chemical behaviour of the cements nor produce structural changes on them. These cements behave as drug delivery systems when soaked in simulated body fluid. The release of the drug is different depending on the composition. For gypsum cements, the cephalexin is quickly released, helped by a dissolution process of the matrix, whereas the drug release is more controlled by the hydroxyapatite presence in hydroxyapatite/gypsum samples. Apatite containing cements do not only show a different drug release process, also the paste viscosity is lower and a faster formation "in vitro" of an apatite-type layer on their surface is observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14751749     DOI: 10.1016/j.biomaterials.2003.09.037

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

1.  Evaluation of colloidal silica suspension as efficient additive for improving physicochemical and in vitro biological properties of calcium sulfate-based nanocomposite bone cement.

Authors:  Shokoufeh Borhan; Saeed Hesaraki; Shaghayegh Ahmadzadeh-Asl
Journal:  J Mater Sci Mater Med       Date:  2010-10-23       Impact factor: 3.896

Review 2.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review.

Authors:  Susmita Bose; Solaiman Tarafder
Journal:  Acta Biomater       Date:  2011-11-20       Impact factor: 8.947

3.  In vitro release kinetics and physical, chemical and mechanical characterization of a POVIAC®/CaCO3/HAP-200 composite.

Authors:  Javier Aragón; Ramón González; Gastón Fuentes; Luca Palin; Gianluca Croce; Davide Viterbo
Journal:  J Mater Sci Mater Med       Date:  2011-12-27       Impact factor: 3.896

4.  In vitro bioactivity, cytocompatibility, and antibiotic release profile of gentamicin sulfate-loaded borate bioactive glass/chitosan composites.

Authors:  Xu Cui; Yifei Gu; Le Li; Hui Wang; Zhongping Xie; Shihua Luo; Nai Zhou; Wenhai Huang; Mohamed N Rahaman
Journal:  J Mater Sci Mater Med       Date:  2013-07-03       Impact factor: 3.896

5.  Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using chitosan and citric acid.

Authors:  Ho-Yeon Song; A H M Esfakur Rahman; Byong-Taek Lee
Journal:  J Mater Sci Mater Med       Date:  2008-12-04       Impact factor: 3.896

6.  Fabrication of a nanoparticle-containing 3D porous bone scaffold with proangiogenic and antibacterial properties.

Authors:  Juan L Paris; Nuria Lafuente-Gómez; M Victoria Cabañas; Jesús Román; Juan Peña; María Vallet-Regí
Journal:  Acta Biomater       Date:  2019-01-14       Impact factor: 8.947

7.  Evaluation of a biodegradable graft substitute in rabbit bone defect model.

Authors:  Xiaobo Yang; Yong Li; Qiang Huang; Jing Yang; Bing Shen; Fuxing Pei
Journal:  Indian J Orthop       Date:  2012-05       Impact factor: 1.251

Review 8.  Marine derived polysaccharides for biomedical applications: chemical modification approaches.

Authors:  Giovanna Gomez d'Ayala; Mario Malinconico; Paola Laurienzo
Journal:  Molecules       Date:  2008-09-03       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.